NYSE:EHC • US29261A1007
The current stock price of EHC is 106.15 USD. In the past month the price increased by 7.88%. In the past year, price increased by 6%.
ChartMill assigns a technical rating of 2 / 10 to EHC. When comparing the yearly performance of all stocks, EHC is a bad performer in the overall market: 67.36% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to EHC. While EHC has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months EHC reported a non-GAAP Earnings per Share(EPS) of 5.46. The EPS increased by 23.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.3% | ||
| ROA | 7.85% | ||
| ROE | 22.71% | ||
| Debt/Equity | 1.01 |
16 analysts have analysed EHC and the average price target is 143.14 USD. This implies a price increase of 34.85% is expected in the next year compared to the current price of 106.15.
For the next year, analysts expect an EPS growth of 7.49% and a revenue growth 8.33% for EHC
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 17.68 | 122.303B | ||
| THC | TENET HEALTHCARE CORP | 14.08 | 20.546B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 9.79 | 14.533B | ||
| ENSG | ENSIGN GROUP INC/THE | 28.97 | 12.445B | ||
| PACS | PACS GROUP INC | 19.72 | 6.39B | ||
| BKD | BROOKDALE SENIOR LIVING INC | N/A | 3.669B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 15.64 | 2.998B | ||
| NHC | NATIONAL HEALTHCARE CORP | N/A | 2.439B | ||
| SGRY | SURGERY PARTNERS INC | 20.66 | 2.003B |
View all stocks in the Health Care Facilities Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Encompass Health Corp. engages in the provision of post-acute healthcare services. The company is headquartered in Birmingham, Alabama. The firm provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. The company operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. The company operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. The company provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
ENCOMPASS HEALTH CORP
9001 Liberty Pkwy
Birmingham ALABAMA 35242 US
CEO: Mark J. Tarr
Employees: 23564
Phone: 12059677116
Encompass Health Corp. engages in the provision of post-acute healthcare services. The company is headquartered in Birmingham, Alabama. The firm provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. The company operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. The company operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. The company provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
The current stock price of EHC is 106.15 USD. The price decreased by -0.38% in the last trading session.
ENCOMPASS HEALTH CORP (EHC) has a dividend yield of 0.71%. The yearly dividend amount is currently 0.62.
EHC has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The next ex-dividend date for ENCOMPASS HEALTH CORP (EHC) is January 2, 2026.
ENCOMPASS HEALTH CORP (EHC) currently has 23564 employees.
ENCOMPASS HEALTH CORP (EHC) will report earnings on 2026-04-22, after the market close.